THE EFFECTS OF PERIOPERATIVE DEXAMETHASONE ON GLYCEMIC CONTROL AND POSTOPERATIVE OUTCOMES.
Objective: Perioperative glucocorticoids are commonly given to reduce pain and nausea in patients undergoing surgery. However, the glycemic effects of steroids, and potential effects on morbidity and mortality, have not been systematically evaluated. This study investigates the association between perioperative dexamethasone and post-operative blood glucose, hospital length of stay (LOS), readmission rates, and ninety-day survival. Methods: Data from 4800 consecutive orthopedic surgery patients who underwent surgery between 2000 and 2016 within a health system were retrospectively analyzed. Results: Patients with and without diabetes who were given a single dose of dexamethasone had higher rates of hyperglycemia during the first twenty-four hours after surgery as compared to those who did not receive dexamethasone (HR (95% CI) for diabetes cohort = 1.81 (1.46, 2.24); HR (95% CI) for non-diabetes cohort = 2.34 (1.66, 3.29)). LOS was nearly one day shorter in patients who received dexamethasone (GMR (95% CI) for patients with diabetes = 0.79 (0.75, 0.83); GMR (95% CI) for patients without diabetes = 0.75 (0.72, 0.79)), and there was no difference in ninety-day readmission rates. In patients without diabetes, dexamethasone was associated with a higher ninety-day overall survival (99.07% versus 96.90%; p=0.004). Conclusions: In patients with and without diabetes who undergo orthopedic surgery, perioperative dexamethasone was associated with a transiently higher risk of hyperglycemia. However, dexamethasone treatment was associated with a shorter LOS in patients with and without diabetes, and a higher overall ninety-day survival rate in patients without diabetes, compared to patients who did not receive dexamethasone.